Cancel
Jean-Marie Cuillerot
Chief Medical Officer
@
Acrivon Therapeutics
p5bqh9wq77@42p07s4.df6
Sign up to see email
See Linkedin
Known information
- Previously served as Chief Medical Officer at Dragonfly Therapeutics.
- Previously served as Chief Medical Officer at Agenus.
- Was the global head of clinical development in immuno-oncology and vice president of clinical immunotherapy and immuno-oncology at EMD Serono.
- Awarded Merck CEO award for leading clinical development of avelumab from pre-IND through global approvals in record time.
- Held clinical development leadership roles at Bristol-Myers Squibb and Novartis.
- Worked as a clinical research physician at Centre d’Immunologie Pierre Fabre, France.
- Served as an assistant professor at the Hôpitaux Universitaires de Strasbourg.
- Received a B.S. in biochemistry from the University Louis Pasteur (Strasbourg, France).
- Received an M.Sc. in cellular and molecular biology from the University Louis Pasteur (Strasbourg, France).
- Received an M.D. from the University Louis Pasteur (Strasbourg, France).
About Acrivon Therapeutics
Acrivon Therapeutics develops precision oncology medicines using a proprietary proteomics-based platform, with its lead candidate ACR-368 in a Phase 2 trial for multiple tumor types.
Report inaccurate information